Genomenon
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Michigan, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3135 S State St Ste 350, Ann Arbor, Mich...Phone Number
(734) 794-3075Website
www.genomenon.comRevenue
$42 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Genomenon
Genomenon is an AI-driven genomics company that organizes the world's genomic knowledge to connect patient DNA to scientific research in the diagnosis and development of treatments for patients with rare genetic diseases and cancer. Genomenon was named Global Company of the Year in Clinical Genomics Interpretation by Frost & Sullivan.Explore more
Genomenon Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Genomenon your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Genomenon had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Genomenon has new funding data
Product Launch: Get notified when Genomenon launches new products
Genomenon, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Genomenon has recently received funding, and reach out quickly before it becomes old news!
Check out if Genomenon is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Genomenon recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Genomenon
Recommended Actions
Reach out to Masked Content who joined Genomenon as Masked Content
Find more new buyers
Compare Similar Companies to Genomenon
Compare insights from companies similar to Genomenon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Genomenon is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Genomenon is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Genomenon.
Genomenon financials insights
Gather financial insights about Genomenon, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Angel/Seed
$1.8M
2020
Debt
$150K
2021
Series A
$5.3M
2022
Series B
$20M
Genomenon Tech Stack
A closer look at the technologies used by Genomenon
Most Recent Scoops
Open Position
Open Position
Open Position
Promotion
Executive Move
Jonathan Eads has recently been promoted from Vice President, Engineering to the role of Chief Technology Officer.
Executive Moves, Promotion
Open Position
Genomenon News & Media
Genomenon and Compass Bioinformatics Partner to Transform Genomic Diagnostics in the U.S. and Japan
Mastermind® FLEX Data powers Compass Bioinformatics's InheriNext® platform, bringing unparalleled genomic evidence to leading institutes across US, Japan, and beyond while advancing precision medicine globally ANN ARBOR, Mich. and TOKYO, Sept. 23, 2025 /PRNewswire/ -- Genomenon, a leading...Golden Helix and Genomenon Announce Strategic Partnership to Advance Clinical Diagnostics
BOZEMAN, Mont., Sept. 2, 2025 /PRNewswire/ -- Golden Helix, a global leader in clinical bioinformatics, today announced a strategic partnership with Genomenon to integrate its Mastermind Genomic Intelligence Platform and Cancer Knowledgebase (CKB) into the Golden Helix software suite....Genomenon and UCB Partner to Advance Thymidine Kinase 2 Deficiency Awareness and Diagnosis
Genomenon's Curation and Distribution of Variant Data to Global Clinical Communities Reduces Barriers to Genetic Diagnosis ANN ARBOR, Mich., July 9, 2025 /PRNewswire/ -- Genomenon, a leader in genomic intelligence, today announced a strategic partnership with UCB to accelerate awareness,...Intelliseq Integrates Genomenon's Cancer Knowledgebase (CKB) into iFlow Platform to Advance Somatic Variant Interpretation
ANN ARBOR, Mich. and SAN DIEGO and KRAKÓW, Poland, June 18, 2025 /PRNewswire/ -- Intelliseq, a leader in computational genomics and digital tools for clinical interpretation of genetic variation, today announced a strategic partnership with Genomenon, the company behind the...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Genomenon
Sign Up For FreeTo access detailed company insights
Genomenon is an AI-driven genomics company that organizes the world's genomic knowledge to connect patient DNA to scientific research in the diagnosis and development of treatments for patients with rare genetic diseases and cancer. Genomenon was named Global Company of the Year in Clinical Genomics Interpretation by Frost & Sullivan.... Read More
